COVID-19 vaccine breakthrough

Vaxine Pty Ltd company logo

Vaxine Pty Ltd company logo

Vaxine's promising new COVID-19 vaccine candidate

Vaxine’s promising new COVID-19 vaccine candidate

A new multivalent COVID-19 vaccine developed by Australian company Vaxine to tackle the new virus variants could be game-changer in the fight against COVID-19

The world desperately needs a vaccine that blocks virus transmission and protects against all the variants. Covax-19 vaccine may soon change history”

— Sharen Pringle, Vaxine Business Mananager

ADELAIDE, SA, AUSTRALIA, May 16, 2021 /EINPresswire.com/ — Professor Petrovsky, who is the Chairman and Research Director of Australian-based Vaxine Pty Ltd, explains that the two biggest challenges to tackling the COVID-19 pandemic are to develop a vaccine that completely prevents virus transmission something other COVID-19 have not been completely successful in achieving, and the second being to find a vaccine that protects equally against all the evolving immune-escape variants.

Professor Petrovsky has been researching coronavirus vaccines for the last 17 years, having previously published scientific papers on vaccines against both the SARS and MERS coronaviruses, which were highly protective in relevant animal models. He also recently published data from a collaboration with the US Army on development of a promising Ebola vaccine that protected mice against this most lethal disease after just a single vaccine dose. He has now successfully taken the same approach to design a protein-based vaccine against COVID-19.

Studies in a broad range of animal models including mice, hamsters, ferrets and monkeys, have recently revealed the high potential of this vaccine that is currently known as Covax-19(TM), but which likely will be soon rebranded as in its latest iteration it moves into late stage human trials in a number of countries.

Recent breakthrough data generated by Vaxine's partner, Professor Kaissar Tabynov who leads the International Center for Vaccinology at the Kazakh National Agrarian University has shown that Vaxine's unique spike protein antigen which is produced using insect cells in culture, was unique in that it not only totally protected hamsters from infection themselves but also prevented them from transmitting the virus to unvaccinated animals that were placed in the same cage two days after the vaccinated animals had been challenged with virus. Protection against transmission was not seen in hamsters given other vaccines making this finding unique to Vaxine's spike protein antigen.

This hamster data reinforced findings in hamster, ferret and monkey challenge study performed by collaborating US Universities, who showed that two doses of Vaxine's Covax-19 vaccine provided complete clearance of recoverable virus from the lungs and nose of animals when sampled just days after an infectious challenge.

"COVAX-19 vaccine has now been shown to be highly protective against the original Wuhan strain of the virus in hamster, ferret and monkey infection models performed by independent academic institutions in multiple countries, attesting to the strength of our protein-based vaccine approach", says Prof. Petrovsky.

"A key element in the success of Covax-19 vaccine is the inclusion of Vaxine's Advax adjuvant technology which acts as a turbocharger to drive an optimal immune response against the virus" explains Prof. Petrovsky who has been working on this promising vaccine adjuvant technology for the last 20 years with funding support from the US National Institutes of Health.

"We have now shown that our COVAX-19 vaccine can provide effective immunity including an ability to block nasal virus replication and this in turn successfully prevents transmission of the virus to vaccine-naïve animals," he explains.

Follow on studies to confirm and expand upon these initial findings are currently underway at several US universities as well as Kazakh National Agrarian University, with a manuscript describing some of the initial animal data currently under review at a leading vaccine journal.

In another major breakthrough the team has now developed the vaccine into a multivariant format designed to protect against all the recently described variant strains of COVID-19, with work also underway on the most recently described Indian strains.

While the data is still preliminary says Prof. Petrovsky, the immune responses to the multivalent vaccine in mice are generating equally strong antibody binding activity against all the major virus variants. “This is extremely exciting as the world desperately needs vaccines able to protect against all the new strains of the virus including the UK, South African and Brazilian strains. By contrast , the currently available vaccines are clearly not as strong against some of these variants as they are against the original Wuhan strain" he explains.

Already there have been multiple confirmed cases of vaccine breakthrough where otherwise healthy individuals who have received mRNA, adenovirus or inactivated whole virus vaccines have become infected generally with either the South African or Brazilian variants.

This problem of immune-escape will only get worse over time as more complex variants emerge which is why Vaxine has been putting all its energy into finding a robust solution to this issue before proceeding with Phase 3 clinical trials of its Covax-19 vaccine.

Dr. Petrovsky went on to conclude “Now we have a multivalent formulation of Covax-19 vaccine that is showing high promise in animal studies, we plan to work as fast as we can to advance this new vaccine formulation in human trials, while expanding manufacturing capacity to ensure we are able to produce enough vaccine to meet the enormous global demand that will be attracted by such a successful vaccine."

"To help us in this task Vaxine is looking to assemble a global network of partner organisations in countries around the world to assist Vaxine with vaccine development, clinical trials, manufacturing, distribution and sales. This is going to be a mammoth effort as we go to war against this insidious virus that continues to wreak havoc around the globe, with WHO recently predicting that the second year of the pandemic is likely to be much worse even than the first, an ominous warning for many countries that still remain poorly prepared and lacking in local vaccine manufacturing capability.

Vaxine wishes to help developing countries to establish their own local state-of-the-art vaccine manufacturing facilities, providing advice on appropriate facility design and undertaking technology transfer of its state of the art protein production technology to such facilities.

Countries in the developing world can no longer afford to sit and wait for outside organisations like COVAX to solve their vaccine supply problems, instead Vaxine proposes to help such countries find their own local solutions to the vaccine supply bottleneck for this.

Sharen Pringle
Vaxine Pty Ltd
437 033 400
email us here
Visit us on social media:
Twitter
LinkedIn


Source: EIN Presswire

Zemits Light Expert 2.0 IPL Laser device now available to MedSpa business in the United States

Aesthetic medical practices and spas can increase their revenue potential with new advanced device

USA, May 14, 2021 /EINPresswire.com/ — Fort Lauderdale, FL – Aesthetic medical practices come in a variety of shapes and sizes from resorts to medical spas. The competition for clients in the MedSpa industry is intense with many individuals continuing to use an aesthetic medical practice as long as they feel like the results warrant the price.

Unfortunately, due to the cut-throat nature of the MedSpa industry, only a small percentage of practices are likely to achieve lucrative, long-term success. Many times, the practices that are the most successful are the ones that offer new, cutting-edge technology to deliver top-quality services to customers.
Advance-Esthetic, a leader in MedSpa equipment sales, has officially launched the Zemits Light Expert 2.0 IPL Laser to the United States aesthetic and spa market. The all-new device could revolutionize the treatments aesthetic medical practices and spas deliver to clients.

The powerful tool offers spa owners multiple functions capable of treating a variety of issues. The Light Expert 2.0 can be used for permanent hair removal, skin rejuvenation, to reduce skin pigmentation, acne therapy, and to remove freckles, facial blemishes, and skin lesions. The ability to use the Light Expert 2.0 in multiple ways means a spa owner can invest in one simple device to treat a number of clients rather than purchasing multiple IPL machines.

The Zemits Light Expert 2.0 works by using selective thermolysis. The technology is similar to lasers an emits a concentrated amount of light energy that is produced by a Xenon flash lamp in the broad spectrum of 400 to 1200 nm. Technicians can change the device’s filter to alter its power.

The MedSpa industry is likely to increase in customers over the next 12 months as the COVID-19 pandemic wears off. More individuals are likely to visit MedSpa businesses seeking treatments they had previously put off in 2020 and early 2021. Resorts and aesthetic medical practices can improve their services to customers by offering multiple treatments with the Light Expert 2.0. For more information on the Zemits Light Expert 2.0, please visit the official Advance-Esthetic product page.

Contact details
Company: Advance-Esthetic
Product: Zemits Light Expert 2.0
Website: Click here
Email: info@advance-esthetic.us

Media Manager
Advance-Esthetic
email us here


Source: EIN Presswire

Duffy Compliance Services Launches CUI-SafeHarbor, a Secure Virtual Environment

Duffy Compliance, home of CUI-SafeHarbor

Duffy Compliance, home of CUI-SafeHarbor

Duffy Compliance, a provider of cybersecurity compliance services is the 1st US-based compliance service provider to offer a CMMC L3 compliant-ready environment

With CUI-SafeHarbor, small businesses can economically create a secured, turn-key environment that will immediately satisfy the technical requirements for CMMC regulation.”

— Shawn Duffy

NEW MARKET, MD, US, May 14, 2021 /EINPresswire.com/ — Duffy Compliance Services, a provider of cybersecurity consulting and compliance services is the first U.S.-based compliance service provider to offer a CMMC Level 3 compliant-ready environment.

For small businesses who are government contractors and must meet the DFARS requirements to work with the DOD, they must protect Controlled Unclassified Information (CUI) and eventually adhere to the Cybersecurity Maturity Model Certification (CMMC). This can be difficult for a small organization in which all or many of its personnel work remotely from laptops. Becoming CMMC-compliant could be a daunting task.

Earlier this year, Duffy Compliance Services launched a cloud-based platform to deliver a secure virtual desktop that provides a protected, managed environment that will not only meet the CMMC Maturity Level 3 requirements, but will also provide an almost instant turn-key CMMC compliance solution.

Duffy Compliance Services provides a full range of cybersecurity analysis services, including compliance audits, penetration testing, and vulnerability assessments. Duffy Compliance serves the following industries: government contractors who supply the Defense Industrial Base (DIB), businesses in the health and human services, and other businesses who want a secure and protected environment.

"We are excited to provide this new product to our clients and to the small government contracting market. These smaller businesses don't often have the resources and funds to throw tens of thousands of dollars at this process,” said President and CEO Shawn Duffy. "With CUI-SafeHarbor, they can economically create a secured, turn-key environment that will immediately satisfy the technical requirements for CMMC regulation."

About Duffy Compliance Services
Duffy Compliance Services is a provider of cybersecurity assessments and compliance services to federal contractors. We are based in Frederick County, Maryland, and have served the Mid-Atlantic region and beyond since 2014. For more information, visit our website at http://www.duffycompliance.com or reach us via email at info@duffycompliance.com.

###

PRESS CONTACT INFORMATION:
Dawn Shuler
Chief Operating Officer
Duffy Compliance Services

Dawn Shuler
Duffy Compliance Services
email us here


Source: EIN Presswire

Northwestern University Honors Prominent Beverly Hills Rhinoplasty Superspecialist

Robert Kotler

Dr. Robert Kotler Recognized for Lifetime Contributions to Medicine

LOS ANGELES, CA, UNITED STATES, May 14, 2021 /EINPresswire.com/ — Dr. Robert Kotler, Beverly Hills rhinoplasty superspecialist, was recently inducted into the Northwestern University Medical School’s Half Century Club.

Members are recognized for their "contributions to the field of Medicine” and are noted as those who "are gifted with a unique historical perspective and education only available to those who have experienced a lifetime of learning."

Dr. Kotler continues to practice "a lifetime of learning." His best-selling medical text, which teaches chemical wrinkle removal, sits in the library of over 5000 MDs. His two Amazon category best-sellers on cosmetic surgery for the public received international attention in print and electronic media.

Two significant medical devices used in nasal and sinus surgery were invented by Dr. Kotler. One, the remarkably simple KOTLER NASAL AIRWAY, fulfills a long-unmet need: improving patient comfort and safety for all nasal and sinus surgeries. “Designing, testing, obtaining FDA-clearance, and acquiring two patents was a major but gratifying project,” notes Dr. Kotler.

A UCLA volunteer faculty member, Dr. Kotler teaches practitioners, medical students, and specialty trainees. Dr. Kotler's commitment to “giving back.” By doing so, thereby fulfilling the directive of one of his favorite and most important teachers, Professor Francis Lederer, of the University of Illinois: "Share your experience."

"Regardless of sparkling technology, such as computerized learning systems and virtual anatomic dissections, Medicine should be taught one-on-one. Seasoned practitioners should be the ones to pass the baton of knowledge and teach skills to the profession's young," notes Dr. Kotler. "Wisdom and technical expertise cannot be acquired exclusively from books or videos. You can build a chair or fix appliances from a manual or YouTube video, but caring for patients passes best from MD to MD."

"In my teaching, I always quote powerhouse advice from a 1929 Harvard Medical School lecture: 'The secret of the care of the patient is caring for the patient.' That one sentence utters the essence of a gratifying and productive practice.”

Dr. Kotler's experience and counsel are valued by his colleagues. Likewise, patients count on sound advice from Dr. Kotler, whose highest level of super-specialization, long experience, and keen communication skills are rare.

Learn more about Dr. Kotler’s practice or schedule a consultation―in-office or virtual―with Dr. Kotler at www.RobertKotlerMD.com.

Aurora DeRose
Boundless Media Inc.
+1 951-870-0099
email us here


Source: EIN Presswire

Media Advisory – Doctors Warn: Cannabis Can Cause Serious Health Hazards

A press conference hosted by the San Diego Marijuana Prevention Initiative

SAN DIEGO, CA, USA, May 14, 2021 /EINPresswire.com/ — What: A virtual (ZOOM) news conference hosted by the Marijuana Prevention Initiative (MPI) to introduce a new and unique medical organization, IASIC (International Association on the Science and Impact of Cannabis); doctors educating on marijuana.

When: Thursday, May 20, 2019 from 10:00am to 11:00am PDT

Who:

DR. RONEET LEV, MD FACEP
Emergency/Addiction Physician / California
Former Chief Medical Officer, White House Office of National Drug Control Policy
ERIC VOTH, MD FACP
President, IASIC
Internal Medicine/ Drug Policy / Kansas
KEN FINN, MD
Vice President, IASIC
Pain Physician / Colorado
Editor, Cannabis in Medicine – An Evidence-Based Approach (Medical Textbook)
CATHERINE ANTLEY, MD
Secretary/ Treasurer, IASIC
Dermatopathologist / Vermont

JOE EBERSTEIN, Facilitator
San Diego Marijuana Prevention Initiative

Where: Online – ZOOM link below

Why: To introduce IASIC, and discuss current cannabis-related trends in emergency and other medical settings, and make available reliable, peer-reviewed medical resources on the short and long-term consequences of cannabis use.

IASIC, the International Academy on the Science and Impact of Cannabis, is a medical organization of doctors who educate on marijuana based on the scientific and medical literature. IASIC is a non-partisan and non-political group created to facilitate informed decisions when considering cannabis policy and law.

Based on the review of the scientific evidence, we conclude that the public health effects of high potency cannabis are harmful. These growing negative impacts further strain health care and addiction treatment resources to the extent that they far surpass taxation revenues. IASIC1.ORG

Contact:
Bernard Gonzales 619-723-0477
Joe Eberstein Office: 619-684-5108; Cell: 619-886-0247

IASIC News Conference Media Link

Please click the link below to join the news conference:

https://us02web.zoom.us/j/87843422190?pwd=MDh6TFVZVXYrQ1ZBaURUdllaNDVXUT09

Passcode: 269763

Or One tap mobile :
US: +16699009128,,87843422190# or +12532158782,,87843422190#

Or Telephone:
Dial(for higher quality, dial a number based on your current location):
US: +1 669 900 9128 or +1 253 215 8782 or +1 346 248 7799 or +1 301 715 8592 or +1 312 626 6799 or +1 646 558 8656

News Conference ID: 878 4342 2190
International numbers available: https://us02web.zoom.us/u/kc4tuD7AMs

Resources and visuals will be available.

Links to local marijuana statistics (San Diego): http://www.ccrconsulting.org/mpi

Bernard Gonzales
Gonzales Communications Consulting
+1 619-723-0477
email us here


Source: EIN Presswire

3D Printed Medical Devices Market Trends And Opportunities In The 3D Printed Medical Devices Market 2021-2030

3D Printed Medical Devices Market Report 2021: COVID-19 Growth And Change To 2030

3D Printed Medical Devices Global Market Report 2021: COVID-19 Growth And Change To 2030

The Business Research Company’s Global3D Printed Medical Devices Market Report 2021 : COVID-19 Growth And Change To 2030

LONDON, GREATER LONDON, UK, May 14, 2021 /EINPresswire.com/ — According to the new market research report ‘3D Printed Medical Devices Global Market Report 2021: COVID-19 Growth And Change To 2030’ published by The Business Research Company, the 3D printed medical devices market is expected to reach expected to reach $2.78 billion in 2025 at a compound annual growth rate of 16.9%. Increasing prevalence of osteoarthritis and similar musculoskeletal conditions is one of the major factors driving the growth of the 3D printed medical devices market.

Request For A Sample For The Global 3D Printed Medical Devices Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2503&type=smp

The 3D printed medical devices market consist of sales of 3D printed medical devices and related services. 3D printing is a process to create three dimensional medical devices with the help of computer-aided design. Some of the 3D printed medical devices include orthopedic and cranial implants, surgical instruments, dental restorations such as crowns, and external prosthetics.

Trends In The Global 3D Printed Medical Devices Market
The increasing use of 3D printing technology in the spine industry is one of the latest trends in the 3D printing medical devices market. The spine industry is adopting 3D printing to produce new innovative products that can promote bone ingrowth and improve implant fixation to spine bone, reduce the number of manufacturing steps, thereby making the 3D printing process more cost-effective in several cases.

Global 3D Printed Medical Devices Market Segments:
The global 3D printed medical devices market is further segmented based on type, application, technology, raw materials, end user and geography.
By Type: Implants, Surgical Instruments, Prosthetics, Tissue Engineering Devices, Others.
By Application: Orthopedic, Spinal, Dental, Hearing Aids, Other.
By Technology: Fused Deposition Modelling, Digital Light Processing, Stereolithography, Selective Laser Melting.
By Raw Material: Plastics, Biomaterial Inks, Metals And Alloys.
By End User: Hospitals, Diagnostics Centers, Academic Institutions, Others.
By Geography: The global 3D printed medical devices market is segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa.

Read More On The Report For The Global 3D Printed Medical Devices Market At:
https://www.thebusinessresearchcompany.com/report/3d-printed-medical-devices-global-market-report

3D Printed Medical Devices Global Market Report 2021 is one of a series of new reports from The Business Research Company that provides 3D printed medical devices market overviews, analyzes and forecasts market size and growth for the global 3D printed medical devices market, 3D printed medical devices global market share, 3D printed medical devices global market players, 3D printed medical devices global market segments and geographies, 3D printed medical devices global market’s leading competitors’ revenues, profiles and market shares. The 3D printed medical devices market report identifies top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.

Read 3D Printed Medical Devices Global Market Report 2021 from The Business Research Company for information on the following:

Data Segmentations: Market Size, Global, By Region And By Country; Historic And Forecast Size, And Growth Rates For The World, 7 Regions And 12 Countries

3D Printed Medical Devices Market Organizations Covered: 3D Systems Corporation, EnvisionTEC, Stratasys Ltd., Arcam AB and Cyfuse Biomedical.

Regions: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.

Countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

Interested to know more about The Business Research Company?

The Business Research Company has published over 1000 industry reports, covering over 2500 market segments and 60 geographies. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. The reports are updated with a detailed analysis of the impact of COVID-19 on various markets. Here is a list of reports from The Business Research Company similar to the 3D Printed Medical Devices Global Market Report 2021:

3D Diagnostic Imaging Services Global Market Report 2021: COVID-19 Growth And Change To 2030
https://www.thebusinessresearchcompany.com/report/3d-diagnostic-imaging-services-market-global-report-2020-covid-19-growth-and-change

3D Printed Implants Global Market Report 2021: COVID-19 Growth And Change To 2030
https://www.thebusinessresearchcompany.com/report/3d-printed-medical-implants-global-market-report

3D Printed Prosthetics Global Market Report 2021: COVID-19 Growth And Change To 2030
https://www.thebusinessresearchcompany.com/report/3d-printed-prosthetics-global-market-report

Call us now for personal assistance with your purchase:
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
info@tbrc.info
Visit us on social media:
Facebook
Twitter
LinkedIn


Source: EIN Presswire

Teen Cousins start PSA for COVID Vaccines – "Just Do IT".

Image of teen boys getting Pfizer COVID Vaccine and promoting awareness on its importance.

Teen boys getting their first dose of Pfizer COVID-19 Vaccine

Middle schoolers raising awareness on the importance of COVID-19 vaccines as the FDA recently approved the Pfizer vaccine for young teens ages 12 to 15.

UNITED STATES, May 14, 2021 /EINPresswire.com/ — Two middle school boys took part in raising awareness on the importance of COVID-19 vaccines as the FDA recently approved the Pfizer vaccine for young teens ages 12 to 15. Cousins Sahil Patel from Cary, NC and Aryan Patel from Cumming GA who are also avid basketball players, thought of using the slogan from one of their favorite brands, ‘Just Do It’ as a message to other young teens to encourage them in also getting vaccinated.

The boys put of their favorite Nike shirts and faced their fears of needles, stepping up to do their part while encouraging their friends to do the same. “With every problem, there should be some solution, this vaccine is our solution” – said Sahil.

The two young teens thought of using the idea of connecting with the sporting brands as many others in their age could related. Using the Nike brand’s slogan of “Just Do It” was the message they wanted to send out when speaking about the importance of getting vaccinated.

“It provided protection for not only myself but others around me and can help stop the mass spreading of COVID-19” – said Aryan.

The two also said that being regular old teens, they just wanted to get this pandemic over with. Getting back to normal times when they could go outside or to a sports game without worrying about the virus was something they are looking forward to.

Realizing that COVID cannot just go away completely they also understand that getting the vaccine will help protect everyone with a better chance of getting back to normal. Both Sahil and Aryan hope that their message is heard by other young teens and can continue getting support from others, such as Nike and sports personalities which many of their friends admire.

Dharmen Patel
Spotlife Asia
info@spotlifeasia.com
Visit us on social media:
Facebook
Twitter


Source: EIN Presswire

The CDC’s Revised Disinfection Guidance Is Fundamentally Flawed

The CDC’s Revised Disinfection Guidance Is Fundamentally Flawed,
Rayne Guest, Founder and CEO, R-Water

DALLAS, TEXAS, UNITED STATES, May 14, 2021 /EINPresswire.com/ — In April 2021, Dr. Rochelle Walensky, the newly named director of the Centers for Disease Control and Prevention (CDC), updated the agency’s guidance on cleaning and disinfecting household and light-touch surfaces.

"Routine cleaning performed effectively with soap or detergent, at least once per day, can substantially reduce virus levels on surfaces," the CDC said.

"Disinfection is only recommended in indoor-setting schools and homes where there has been a suspected or confirmed case of COVID-19, within the last 24 hours," Dr. Walensky further expanded.

The CDC has long stated that one of the most significant ways to spread germs is by touching surfaces and then touching your face, eyes, or nose. They have also stated that germs do not move themselves, they depend on people, the environment, and surfaces. So, why during a global pandemic is the CDC downplaying the importance of disinfecting surfaces?

The shifting guidance frankly defies logic and has left healthcare and disinfection specialists alike shaking their heads in disbelief. If our common goal is to keep people out of hospitals and to work towards a return to normalcy, we should utilize all the tools at our disposal to prevent COVID and other infectious diseases.

By dispelling five myths about the CDC’s revised disinfection guidance, we can adopt safe and sustainable long-term practices.

MYTH: We only need to disinfect if there was a known COVID case within the past 24 hours.
False, this is reactive advice rather than preventative guidance. As research shows, COVID can be transmitted by people who are asymptomatic, making it virtually impossible to know if a person with the virus has been in the space.

MYTH: I wash my hands regularly, that should be enough.
False, a 2015 behavioral study revealed that the people observed touched their faces an average of 23 times per hour. Playing this out in a common setting: you wash your hands before sitting down at a table that was not properly disinfected, you touch the surface, and then you touch your face. This is further compounded by the fact that we place government and CDC mandated face coverings on these surfaces and then put them on our faces for prolonged periods of time.

MYTH: COVID is the only bug in the game.
False, there are thousands of pathogens that cause infectious disease. CDC stands for Centers for Disease Control and Prevention and their guidance should encompass all infectious diseases, not solely COVID. COVID, after all is the easiest type of virus to kill.

As an example, historically Healthcare Acquired Infections (HAI) have infected millions and claim the lives of over 100,000 in the U.S. alone each year. This is an astounding 6% death rate. Rather than provide guidance to help ensure that these pathogens, including MRSA and C. diff, that cause HAIs are eradicated as well, the government has allowed hospitals to STOP reporting them.

MYTH: The surface is safe, it was just sprayed and wiped down.
False, all products have a contact time, or period that it must remain wet on the surface to be effective. If a product’s contact time, which is generally 10 minutes, is not adhered to, pathogens are not eliminated thoroughly, making them likely to spread. This includes COVID, which lands on surfaces after being suspended in air.

MYTH: Disinfectant on the CDC and EPA recommended List N are practical to use in the fight against COVID.
False, List N, the EPA’s compilation of disinfectants viewed by facilities teams and risk assessors as the holy grail of products that should be used in the fight against COVID is mostly comprised of products with a 10-minute contact time and ingredients known to be respiratory irritants.

This contradicts the CDC’s long-standing, pre-COVID guidance of using products with the shortest contact time possible. Common sense would also tell you to not use products that are known respiratory irritants, as they make people more vulnerable to respiratory illnesses and exasperate the symptoms of people suffering from respiratory diseases such as asthma, COPD, and COVID.

Maddy Berry
Rubenstein PR
+1 2128053093
mberry@rubensteinpr.com


Source: EIN Presswire

OrlandoJobs.com to host HIREpalooza Virtual Career Fair May 18-19, Job Seekers Set Interview Directly With Employers

Jobs in Orlando Florida

Central Florida job seekers will be able to schedule interviews with the employers they want to work for at HIREpalooza- May 18-19th

Job seekers can set zoom interviews directly with awesome Central Florida employers at HIREpalooza. Today's job seekers have all the leverage and it is time find a great job!”

— Roger Lear

ORLANDO, FLORIDA, USA, May 14, 2021 /EINPresswire.com/ — Central Florida job seekers will be able to schedule interviews with the employers they want to work for at OrlandoJobs.com presents HIREpalooza, happening May 18 and 19, 2021, from 9 am-6 pm. This event will feature over 60 Central Florida employers with open positions in various job categories, such as hospitality, healthcare, and education.

"Post COVID Hiring is alive and well! Tons of jobs but job seekers are sitting on the sideline. This event allows job seekers to set zoom interview with one or 65 Central Florida employers directly," states Roger Lear, President of OrlandoJobs.com. "For job seekers struggling to get interviews, or would like have 10 interviews in two days, this event will be a direct line to the hiring manager. For anyone looking for a job, this is an event not to be missed."

In addition to the live interviews, this event will feature career advice sessions from local career experts. Relevant topics to be discussed will include resume optimization, job searching techniques, and video interviewing preparation. HIREpalooza will also offer resume review sessions where job seekers can get helpful resources for crafting the best resume for the jobs they want. All open jobs will also be posted within the virtual career fair platform for 30 days starting May 18th.

OrlandoJobs is also partnering with Orlando Weekly and City District, along with the nine other Orlando Maine Street Districts, to provide free virtual booth space and five free job listings to Central Florida bars and restaurants in response to the workforce shortage.

"We have the virtual platform and are producing the job fair, Orlando Weekly has the voice to get the word out, and the Main Street Districts are connected to these businesses on the street level," said Scott Kotroba, co-founder of OrlandoJobs.com. "And all of us have a long history of working with bars and restaurants in Central Florida. They are essential workers for us. It just made sense for us to come together and try to help."

Companies participating in HIREpalooza include Tavistock Restaurant Group, Central Florida YMCA, Sonny's, Wendy's Corporation, Universal Orlando, Orlando Health, Orange County Public Schools, Aldi, and BJ’s. For more information, and to register for the event, visit the HIREpalooza event page. https://events.orlandojobs.com/events/orlandojobs-com-presents-hirepalooza-2021/

About OrlandoJobs.com: OrlandoJobs.com, part of the Great Job Spot Network, is the powerful, pre-eminent career platform in Central Florida. With more than 100,000 visitors per month and over 2,400 employers, there is no better place to find a job. The site was founded in 2005 by Roger Lear and Scott Kotroba and is the official employment website of the Great Orlando Society of Human Resources (www.GoSHRM.org).

Alyssa Barker
OrlandoJobs.com
+1 407-645-4224
email us here
Visit us on social media:
Facebook
Twitter


Source: EIN Presswire

Global Insulin Drugs Market Trends, Strategies, And Opportunities In The Insulin Drugs Market 2021-2030

Insulin Drugs Market Report 2021: COVID-19 Growth And Change To 2030

Insulin Drugs Global Market Report 2021: COVID-19 Growth And Change To 2030

The Business Research Company’s Insulin Drugs Global Market Report 2021: COVID-19 Growth And Change To 2030

LONDON, GREATER LONDON, UK, May 14, 2021 /EINPresswire.com/ — According to the new market research report ‘Insulin Drugs Global Market Report 2021: COVID-19 Growth And Change To 2030’ published by The Business Research Company, the insulin drugs market is expected to reach $32.05 billion in 2025 at a compound annual growth rate of 4%. Changing lifestyles are leading to a higher prevalence of diabetes. This is expected to drive the demand for diabetes drugs during the forecast period.

Request For A Sample For The Global Insulin Drugs Market Report:
https://www.thebusinessresearchcompany.com/report/insulin-drugs-global-market-report

The insulin drugs market consists of manufacturers’ sales of insulin drugs and types of insulin by entities (organizations, sole traders and partnerships) which are used to treat diabetes. Insulin is a medication prescribed to treat type 1 diabetes and type 2 diabetes mellitus. There are several types, preparations, and dosage amount of insulin. Insulin is a hormone that is produced naturally in our bodies. Its main role is to allow cells throughout the body to uptake glucose (sugar) and convert it into a form that can be used by these cells for energy. The market covered in this report does not include non-insulin drugs and other antidiabetic drugs or medicine.

Trends In The Global Insulin Drugs Market
There is an increased trend of mergers and acquisitions for the new formulations in the insulin market and the companies are investing in development of new medicines. For example, researchers at Lund University Diabetes Centre in Sweden, worked on CRISPR, a genome modification tool.

Global Insulin Drugs Market Segments:
The global insulin drugs market is further segmented based on product type, application, drug classification and geography.
By Product Type: Basal or Long-Acting Insulins, Bolus or Fast-Acting Insulins, Traditional Human Insulins, Combination Insulins, Biosimilar Insulins.
By Application: Type II Diabetes, Type I Diabetes, Gestational Diabetes, Prediabetes.
By Drug Classification: Branded Drugs, Generic Drugs.
By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Drugs Stores, Others.
By Geography: The global insulin drugs market is segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa.

Read More On The Report For The Global Insulin Drugs Market At:
https://www.thebusinessresearchcompany.com/report/insulin-drugs-global-market-report

Insulin Drugs Global Market Report 2021 is one of a series of new reports from The Business Research Company that provides insulin drugs global market overviews, analyzes and forecasts market size and growth for the global insulin drugs market, insulin drugs global market share, insulin drugs global market players, insulin drugs global market segments and geographies, insulin drugs global market’s leading competitors’ revenues, profiles and market shares. The insulin drugs global market report identifies top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.

Read Insulin Drugs Global Market Report 2021 from The Business Research Company for information on the following:

Data Segmentations: Market Size, Global, By Region And By Country; Historic And Forecast Size, And Growth Rates For The World, 7 Regions And 12 Countries

Insulin Drugs Market Organizations Covered: Apidra, Eli Lilly, Humalog, Humulin, Insuman, Lantus, Levemir, Novo Nordisk, Novomix, and NovoRapid/Novolog.

Regions: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.

Countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

Interested to know more about The Business Research Company?

The Business Research Company has published over 1000 industry reports, covering over 2500 market segments and 60 geographies. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. The reports are updated with a detailed analysis of the impact of COVID-19 on various markets. Here is a list of reports from The Business Research Company similar to the Insulin Drugs Global Market Report 2021:

Insulin Pens, Syringes, Pumps And Injectors Market – By Devices (Pens, Injectors And Pumps, Syringes), By End-User (Homecare, Hospitals And Others), By Expenditure (Private, Public Healthcare), And By Region, Opportunities And Strategies – Global Forecast To 2030
https://www.thebusinessresearchcompany.com/report/insulin-pens-syringes-pumps-and-injectors-market

Blood Glucose Meters Global Market Report 2021: COVID-19 Impact And Recovery To 2030
https://www.thebusinessresearchcompany.com/report/blood-glucose-meters-global-market-report

Diabetes Care Devices Global Market Report 2021: COVID-19 Implications And Growth To 2030
https://www.thebusinessresearchcompany.com/report/diabetes-care-devices-global-market-report

Call us now for personal assistance with your purchase:
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
info@tbrc.info
Visit us on social media:
Facebook
Twitter
LinkedIn


Source: EIN Presswire